Top

Published in:

01-08-2015 | Review Article

Hybrid PET/MR imaging: physics and technical considerations

Authors: Shetal N. Shah, Steve S. Huang

Published in: Abdominal Radiology | Issue 6/2015

Abstract

In just over a decade, hybrid imaging with FDG PET/CT has become a standard bearer in the management of cancer patients. An exquisitely sensitive whole-body imaging modality, it combines the ability to detect subtle biologic changes with FDG PET and the anatomic information offered by CT scans. With advances in MR technology and advent of novel targeted PET radiotracers, hybrid PET/MRI is an evolutionary technique that is poised to revolutionize hybrid imaging. It offers unparalleled spatial resolution and functional multi-parametric data combined with biologic information in the non-invasive detection and characterization of diseases, without the deleterious effects of ionizing radiation. This article reviews the basic principles of FDG PET and MR imaging, discusses the salient technical developments of hybrid PET/MR systems, and provides an introduction to FDG PET/MR image acquisition.

Fowler JS, Ido T (2002) Initial and subsequent approach for the synthesis of 18FDG. Semin Nucl Med 32:6–12PubMedCrossRef

Reivich M, Kuhl D, Wolf A, et al. (1977) Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose. Acta Neurol Scand 64:190–191

Som P, Atkins HL, Bandoypadhyay D, et al. (1980) A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21:670–675PubMed

Wahl RL, Quint LE, Cieslak RD, et al. (1993) “Anatometabolic” tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 34:1190–1197PubMed

Levin DN, Pelizzari CA, Chen GT, Chen CT, Cooper MD (1988) Retrospective geometric correlation of MR, CT, and PET images. Radiology 169:817–823PubMedCrossRef

Townsend DW (2008) Combined positron emission tomography-computed tomography: the historical perspective. Semin Ultrasound, CT, MR 29:232–235CrossRef

Veit-Haibach P, Kuhn FP, Wiesinger F, Delso G, von Schulthess G (2013) PET-MR imaging using a tri-modality PET/CT-MR system with a dedicated shuttle in clinical routine. Magn Reson Mater Phys Biol Med 26:25–35CrossRef

Zaidi H, Ojha N, Morich M, et al. (2011) Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol 56:3091–3106PubMedCentralPubMedCrossRef

Shao Y, Cherry SR, Farahani K, et al. (1997) Simultaneous PET and MR imaging. Phys Med Biol 42:1965–1970PubMedCrossRef

10.

Bindseil GA, Gilbert KM, Scholl TJ, Handler WB, Chronik BA (2011) First image from a combined positron emission tomography and field-cycled MRI system. Magn Reson Med 66:301–305PubMedCrossRef

11.

Delso G, Furst S, Jakoby B, et al. (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 52:1914–1922PubMedCrossRef

12.

Wagenknecht G, Kaiser HJ, Mottaghy FM, Herzog H (2013) MRI for attenuation correction in PET: methods and challenges. Magn Reson Mater Phys Biol Med 26:99–113CrossRef

13.

Wurslin C, Schmidt H, Martirosian P, et al. (2013) Respiratory motion correction in oncologic PET using T1-weighted MR imaging on a simultaneous whole-body PET/MR system. J Nucl Med 54:464–471PubMedCrossRef

14.

Brendle CB, Schmidt H, Fleischer S, et al. (2013) Simultaneously acquired MR/PET images compared with sequential MR/PET and PET/CT: alignment quality. Radiology 268:190–199PubMedCrossRef

15.

Schoder H, Larson SM (2004) Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 34:274–292PubMedCrossRef

16.

Adams S, Baum R, Rink T, et al. (1998) Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25:79–83PubMedCrossRef

17.

Montravers F, Kerrou K, Nataf V, et al. (2009) Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors. J Clin Endocrinol Metab 94:1295–1301PubMedCrossRef

18.

Haug AR, Cindea-Drimus R, Auernhammer CJ, et al. (2014) Neuroendocrine tumor recurrence: diagnosis with 68 Ga-DOTATATE PET/CT. Radiology 270:517–525PubMedCrossRef

19.

Afshar-Oromieh A, Malcher A, Eder M, et al. (2012) PET imaging with a [68 Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging 40:486–495PubMedCrossRef

20.

Levin C, Glover G, Deller T, et al. (2013) Prototype time-of-flight PET ring integrated with a 3T MRI system for simultaneous whole-body PET/MR imaging. J Nucl Med Meeting Abstr 54:148

Title: Hybrid PET/MR imaging: physics and technical considerations
Authors: Shetal N. Shah
Steve S. Huang
Publication date: 01-08-2015
Publisher: Springer US
Published in: Abdominal Radiology / Issue 6/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-015-0443-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Hybrid PET/MR imaging: physics and technical considerations

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2015

Lymphatic pathway around the pancreatic head and extrahepatic bile duct: evaluation using MR imaging at 3.0-T

The Lone Ranger’s mask sign

Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis

Value of bimodal 18F-choline-PET/MRI and trimodal 18F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy

The onion ring sign

Use of enhanced T2 star-weighted angiography (ESWAN) and R2* values to distinguish ovarian cysts due to endometriosis from other causes

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page